My blood pressure remains elevated despite chronic kidney disease and being on metoprolol succinate 50 mg; which antihypertensive medication should I add?

Recommended Blood Pressure Medication to Add in CKD

Add an ACE inhibitor (such as lisinopril) or ARB (such as losartan or telmisartan) to your current metoprolol regimen, particularly if you have any degree of albuminuria. 1

Primary Recommendation: RAS Inhibition

The KDIGO 2021 guidelines provide clear, evidence-based direction for adding antihypertensive therapy in CKD patients already on beta-blockers:

If You Have Albuminuria (Protein in Urine):

• Severely increased albuminuria (A3): ACE inhibitor or ARB is strongly recommended regardless of diabetes status 1
• Moderately increased albuminuria (A2): ACE inhibitor or ARB is recommended, with stronger evidence if you have diabetes 1
• No albuminuria: ACE inhibitor or ARB is still reasonable to consider 1

Dosing Strategy:

• Use the highest approved dose that you can tolerate to achieve maximum kidney and cardiovascular protection 1
• The proven benefits in clinical trials were achieved with full therapeutic doses, not low doses 1

Critical Monitoring Requirements

After starting an ACE inhibitor or ARB, you must have laboratory monitoring 1:

• Check blood pressure, serum creatinine, and potassium within 2-4 weeks of starting or increasing the dose 1
• Continue the medication unless creatinine rises >30% within 4 weeks of initiation 1
• Hyperkalemia can often be managed with dietary changes or potassium binders rather than stopping the RAS inhibitor 1

Alternative: Diuretic Addition

If RAS inhibition is contraindicated or not tolerated, adding a thiazide-type diuretic (such as hydrochlorothiazide 12.5-25 mg) or chlorthalidone is an effective alternative 1, 2:

• The combination of metoprolol plus hydrochlorothiazide has proven efficacy and safety in CKD patients 2, 3, 4
• This combination is more effective than either agent alone 2
• Low-dose hydrochlorothiazide (12.5 mg) combined with metoprolol is as effective as higher doses with fewer side effects 4

Blood Pressure Target

Aim for systolic BP <120 mmHg when tolerated, using standardized office measurements 1:

• This intensive target is supported by KDIGO 2021 guidelines for CKD patients 1
• Most CKD patients require ≥2 antihypertensive medications to achieve adequate control 1

Important Caveats

What NOT to Do:

• Never combine an ACE inhibitor with an ARB (or add a direct renin inhibitor to either) - this increases harm without benefit 1
• Avoid applying the <120 mmHg target to non-standardized BP measurements as this can lead to overtreatment 1

When to Consider Calcium Channel Blockers:

• Dihydropyridine CCBs (such as amlodipine) are reasonable alternatives if RAS inhibitors cause intolerable side effects 1
• CCBs are particularly effective in certain populations and can be combined with RAS inhibitors 1

Special Consideration for Resistant Hypertension:

• If BP remains elevated on 3 medications, mineralocorticoid receptor antagonists (such as spironolactone or finerenone) can be effective 1
• However, these carry higher risk of hyperkalemia, especially with lower kidney function 1

Practical Algorithm

1. First: Determine albuminuria status (urine albumin-to-creatinine ratio)
2. If any albuminuria present: Add ACE inhibitor or ARB at standard starting dose
3. If no albuminuria: ACE inhibitor/ARB still preferred, but diuretic is reasonable alternative
4. Monitor labs in 2-4 weeks: Accept creatinine rise up to 30% and manage hyperkalemia medically
5. Titrate to maximum tolerated dose of RAS inhibitor over subsequent weeks
6. If BP still not at goal: Add third agent (diuretic if on RAS inhibitor, or CCB)

The evidence strongly supports RAS inhibition as the next step in your regimen, as it provides both blood pressure control and kidney protection beyond what metoprolol alone can achieve 1, 5, 6.